142 related articles for article (PubMed ID: 16753966)
1. Nebulization of liposomal rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer.
Wagner A; Vorauer-Uhl K; Katinger H
J Liposome Res; 2006; 16(2):113-25. PubMed ID: 16753966
[TBL] [Abstract][Full Text] [Related]
2. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
3. Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.
Li Z; Perkins W; Cipolla D
Eur J Pharm Biopharm; 2021 Sep; 166():10-18. PubMed ID: 34082122
[TBL] [Abstract][Full Text] [Related]
4. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
6. Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.
Elhissi A; Gill H; Ahmed W; Taylor K
J Liposome Res; 2011 Jun; 21(2):173-80. PubMed ID: 20684671
[TBL] [Abstract][Full Text] [Related]
7. That's cool!--Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer.
Hertel S; Pohl T; Friess W; Winter G
Eur J Pharm Biopharm; 2014 Jul; 87(2):357-65. PubMed ID: 24662437
[TBL] [Abstract][Full Text] [Related]
8. Nebulization and
Mišík O; Kejíková J; Cejpek O; Malý M; Jugl A; Bělka M; Mravec F; Lízal F
Mol Pharm; 2024 Apr; 21(4):1848-1860. PubMed ID: 38466817
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Comparison of a Vibrating Mesh Nebulizer Operating in Inspiratory Synchronized and Continuous Nebulization Modes During Noninvasive Ventilation.
Michotte JB; Staderini E; Le Pennec D; Dugernier J; Rusu R; Roeseler J; Vecellio L; Liistro G; Reychler G
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):328-36. PubMed ID: 27310926
[TBL] [Abstract][Full Text] [Related]
10. Long term stability of rh-Cu/Zn-superoxide dismutase (SOD)-liposomes prepared by the cross-flow injection technique following International Conference on Harmonisation (ICH)-guidelines.
Vorauer-Uhl K; Wagner A; Katinger H
Eur J Pharm Biopharm; 2002 Jul; 54(1):83-7. PubMed ID: 12084506
[TBL] [Abstract][Full Text] [Related]
11. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
[TBL] [Abstract][Full Text] [Related]
12. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
[TBL] [Abstract][Full Text] [Related]
13. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.
Elhissi A; Hidayat K; Phoenix DA; Mwesigwa E; Crean S; Ahmed W; Faheem A; Taylor KM
Int J Pharm; 2013 Feb; 444(1-2):193-9. PubMed ID: 23299083
[TBL] [Abstract][Full Text] [Related]
14. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion.
Abu-Dahab R; Schäfer UF; Lehr CM
Eur J Pharm Sci; 2001 Aug; 14(1):37-46. PubMed ID: 11457648
[TBL] [Abstract][Full Text] [Related]
15. The effects of freeze-drying on the stability of liposomes to jet nebulization.
Bridges PA; Taylor KM
J Pharm Pharmacol; 2001 Mar; 53(3):393-8. PubMed ID: 11291755
[TBL] [Abstract][Full Text] [Related]
16. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
[TBL] [Abstract][Full Text] [Related]
17. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate.
Desai TR; Tyrrell GJ; Ng T; Finlay WH
Pharm Res; 2003 Mar; 20(3):442-7. PubMed ID: 12669966
[TBL] [Abstract][Full Text] [Related]
19. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers.
Gaspar MM; Gobbo O; Ehrhardt C
J Liposome Res; 2010 Mar; 20(1):55-61. PubMed ID: 19580376
[TBL] [Abstract][Full Text] [Related]
20. Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients.
Rottier BL; van Erp CJ; Sluyter TS; Heijerman HG; Frijlink HW; Boer AH
J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):263-9. PubMed ID: 19466906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
